In previous studies, we successfully constructed a dual-modality molecular probe that targets pancreatic cancer by utilizing chitosan-encapsulated magnetic nanoparticles as a carrier and targeting the survivin gene. This evidence concerns the gene BIRC5 and pancreatic neoplasm.